Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

viatris limited - ethinylestradiol 0.0306mg; levonorgestrel 0.15mg - film coated tablet - active: ethinylestradiol 0.0306mg levonorgestrel 0.15mg excipient: acacia disodium edetate   ethylcellulose lactose monohydrate macrogol 6000 magnesium stearate maize starch methyl hydroxybenzoate microcrystalline cellulose polacrilin potassium purified talc sucrose   titanium dioxide calcium carbonate carnauba wax glycerol iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   purified water sucrose titanium dioxide - oral contraception

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.5mg;   - pessary - 0.5 mg - active: estriol 0.5mg   excipient: hard fat - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 2mg;   - tablet - 2 mg - active: estriol 2mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate potato starch povidone - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. climacteric complaints such as hot flushes and night sweating. a diagnostic aid in case of a doubtful atropic cervical smear. infertility due to cervical hostility.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.1%{relative};   - vaginal cream - 0.1 % - active: estriol 0.1%{relative}   excipient: cetyl alcohol chlorhexidine hydrochloride glycerol lactic acid octyldodecanol polysorbate 60 purified water sodium hydroxide sorbitan stearate spermaceti stearyl alcohol - atrophy of the lower urogenital tract related to oestrogen deficiency, notably: · for the treatment of vaginal complaints such as dyspareunia, dryness and itching. · for the prevention of recurrent infections of the vagina and lower urinary tract. · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

bayer new zealand limited - norethisterone 5mg;   - tablet - 5 mg - active: norethisterone 5mg   excipient: lactose monohydrate magnesium stearate maize starch

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ethinylestradiol 20ug;  ;  ; levonorgestrel 100ug;   - film coated tablet - active: ethinylestradiol 20ug     levonorgestrel 100ug   excipient: gelatin hypromellose lactose monohydrate macrogol 4000 magnesium stearate maize starch titanium dioxide - oral contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ethinylestradiol 30ug;  ;  ; levonorgestrel 150ug;   - film coated tablet - active: ethinylestradiol 30ug     levonorgestrel 150ug   excipient: gelatin hypromellose iron oxide yellow lactose monohydrate macrogol 4000 magnesium stearate maize starch titanium dioxide - oral contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ethinylestradiol 20ug;  ;  ; levonorgestrel 100ug;   - film coated tablet - active: ethinylestradiol 20ug     levonorgestrel 100ug   excipient: gelatin hypromellose lactose monohydrate macrogol 4000 magnesium stearate maize starch titanium dioxide gelatin hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate maize starch titanium dioxide - oral contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ethinylestradiol 30ug;  ;  ; levonorgestrel 150ug;   - film coated tablet - active: ethinylestradiol 30ug     levonorgestrel 150ug   excipient: gelatin hypromellose iron oxide yellow lactose monohydrate macrogol 4000 magnesium stearate maize starch purified water titanium dioxide gelatin hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate maize starch titanium dioxide - oral contraception.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - itraconazole 100mg;   - capsule - 100 mg - active: itraconazole 100mg   excipient: erythrosine gelatin   hypromellose indigo carmine macrogol 20000 sugar spheres titanium dioxide - sporanox capsules are indicated for the following conditions: - treatment of vulvovaginal candidiasis. - treatment of pityriasis versicolor. - treatment of dermatomycosis – including highly keratinised regions as in plantar tinea pedis and palmer tinea manus. - treatment of fungal keratitis. - treatment of oral candidiasis. - treatment of onychomycosis caused by dermatophytes and/or yeasts. - systemic mycoses, only in the following fungal infections: o treatment of systemic aspergillosis and candidiasis, o treatment of histoplasmosis, o histoplasmosis, maintenance therapy only in aids patients. o treatment of sporotrichosis (including lymphocutaneous/cutaneous and extracutaneous), o treatment of paracoccidioidomycosis, o treatment of chromomycosis, o treatment of blastomycosis.